Health execs: Advice I would give my younger self May 07, 2016By Aubrey WestgateLooking back on your career, what advice do you wish you had starting out? Here’s what our editorial advisory board said.
In this issue
Impact of Medicare's expanded benzodiazepine coverageLike any medication, benzodiazepines should be used with caution. However, the tremendous expenditure for these medications—just a year after Medicare Part D extended its coverage to include them in 2012—has some wondering why so many of these drugs are being prescribed. Will wearables and healthcare ever sync? May 03, 2016By Donna MarburyThough technology companies are continuing to innovate in the wearable field, healthcare organizations are slow to adapt. Five strategies that drive higher value care May 05, 2016By Doug ChaetDoug Chaet, senior vice president, Provider Networks and Value-Based Solutions at Independence Blue Cross, shares five strategies that can help providers succeed in value-based reimbursement models. Pharma coupons: pros and cons May 04, 2016By Mari EdlinDrug coupons sound good on paper for both manufacturers who sell more products and for patients who pay less for a high-priced new product. But payers and pharmacy benefits managers are not impressed. Cardiovascular drugs: Current spending, future outlook May 06, 2016By Tracey WalkerCardiovascular drugs are among the most widely used, since their indications are far reaching and address conditions that are prevalent among a large population. Blue Shield of California CEO shares ACO success secrets May 07, 2016By Aubrey WestgateInsight from Paul Markovich, CEO, Blue Shield of California